Oseltamivir® News 

DOH distributes 5,000 Tamiflu tablets in Region 12
Found on 02 Jul 2009 09:26 GMT

The Department of Health has distributed at least 5,000 tablets of Tamiflu for government hospitals and rural health units in Region 12 as part of its continuing campaign against the spread of influenza A or swine flu virus in the country.

Roche offers Tamiflu to developing nations
Found on 01 Jul 2009 17:01 GMT

Swiss pharmaceutical giant Roche has announced it is launching a programme to produce and store anti-flu drug Tamiflu pandemic stockpiles for developing countries at a sharply discounted price.

Denmark finds 1st case of H1N1 resistance to Tamiflu
Found on 29 Jun 2009 19:40 GMT

Scientists have established the first case of the new H1N1 influenza strain showing resistance to Tamiflu, the main antiviral flu drug, Danish officials and the manufacturer said on Monday.

Another firm wins Tamiflu licence
Found on 01 Apr 2006 00:28 GMT
Swiss drugmaker Roche Holding AG said yesterday that it had granted a sub-licence to a Shenzhen-based pharmaceutical company to produce Tamiflu, believed to be the most effective medicine against bird flu.

The deal allows Shenzhen-based HEC Group to produce the generic form of Tamiflu known as oseltamivir for use in pandemic prevention and control. The drug will be supplied through governm...

WHO wants to know more about Tamiflu
Found on 19 Mar 2006 12:14 GMT
The World Health Organization has called for urgent studies on Roche's flu drug Tamiflu to determine its effectiveness in the fight against bird flu in humans. In a statement from its Geneva headquarters, the WHO said there was no clinical evidence of the anti-viral drug's efficacy against the deadly H5N1 virus. But it reaffirmed that Tamiflu should be used to treat suspected cases and to p...

China begins clinical studies on Tamiflu
Found on 19 Mar 2006 12:12 GMT
China has given the go ahead to a Shanghai-based pharmaceutical firm to begin clinical studies on the effectiveness of Tamiflu drug that is believed to be the best form of defence against bird flu in humans.

The drug will be manufactured by Shanghai Sunve Pharmaceutical Co., Ltd under a licensing arrangement with Swiss drug producer Roche.

The study will seek to establish if the Tamiflu produ...

Tamiflu back on the market
Found on 16 Mar 2006 13:16 GMT
Roche Canada has resumed sales of its sought-after flu drug Tamiflu to regular pharmacies in Canada. But a company official says efforts are being made to keep Canadian supplies from flowing to Internet pharmacies. Some of those Internet outlets have been taking advantage of pandemic fears by selling the scarce drug at huge mark-ups. That discrepancy is why Roche stopped distributing to phar...

Influenza crisis Is Tamiflu enough
Found on 10 Mar 2006 22:15 GMT
Indeed, influenza has proved to be a potential epidemic stuff in the recent history. According to the health figures, up to 60 million Americans develop flu each year and more than 200,000 are hospitalized. During the past epidemics in the US, influenza and its complications caused more than 500,000 deaths.

The latest health scare worldwide is the avian influenza that has spread its tentacles ...

Indonesia plans massive increase in Tamiflu
Found on 10 Mar 2006 22:11 GMT
Indonesia, which has suffered more deaths from bird flu this year than any other country, plans a massive increase in its supply of anti-flu Tamiflu tablets, the Jakarta Post newspaper reported on Sunday.

If taken within two days of contracting the virus, Tamiflu can work against the often deadly H5N1 flu, which international tests show has killed nine people in Indonesia so far in 2006.

The ...

Japanese researchers find new way to make Tamiflu
Found on 03 Mar 2006 12:05 GMT
A team of Japanese researchers has developed a new way of producing the anti-flu drug Tamiflu that does not rely on natural ingredients and may help ensure more stable supplies, the head of the team said. Tamiflu, produced by Swiss-based pharmaceutical company Roche Holding AG , is considered one of the best defences against bird flu in humans, and there are fears of a possible shortage in the...

Japanese Tamiflu Is Easier To Make
Found on 28 Feb 2006 12:47 GMT
Scientists in Japan have cornered a big breakthrough in the quest to find easier ways of making the Tamiflu drug easier to produce. The scientists made their Tamiflu from petroleum based compounds which could help to ease the problems of excess demand and poor supply of the drug. The scientists from the University of Tokyo stated that they were able to make Tamiflu without having to resort to...

Tokyo U develops better Tamiflu formula
Found on 27 Feb 2006 21:02 GMT
A group of researchers at Tokyo University has developed a formula to produce the antiflu medicine Tamiflu using a petrochemical material instead of the plant-based ingredient used currently. The group, headed by Prof. Masakatsu Shibasaki of the Tokyo University Graduate School of Pharmaceutical Sciences, said the new method would ensure the stable supply of the antiviral drug in the face of s...

Hetero Drugs avails two lakh capsules of Tamiflu
Found on 23 Feb 2006 23:18 GMT
City-based Hetero Drugs would avail two lakh capsules of Tamiflu to the government and has made clear that there was enough stock of drug in the country.

The current capacity of the company is that it could produce 13 million capsules per month, which could be scaled up to 60 million capsules.

The company has Active Pharmaceutical Ingredient of the drug equivalent of one million capsules in ...

The cost effectiveness of zanamivir and oseltamivir for influenza treatment
ABSTRACT In this month's column, the authors evaluate the cost effectiveness of oseltamivir and zanamivir, compared with standard care, for the treatment of influenza. Using efficacy data from randomized, placebo-controlled clinical trials, a cost-effectiveness model was constructed. In an

Publication: Formulary

New Data Proves Oseltamivir Effective Against Human H5N1 and Avian H5N1 Influ...
WASHINGTON, Oct. 31 /PRNewswire/ - InterScience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington DC, 2nd November 2004 - New data presented confirm that oseltamivir (Tamiflu), an oral neuraminidase inhibitor (NAI), is effective against the human H5N1 and avian H5N1

Publication: PR Newswire

Oseltamivir Effective Against Influenza Virus, Doesn't Impact Immune Factors....
2000 MAY 28 - (NewsRx.com) - Oseltamivir, an antiviral agent known to be effective against influenza virus A and B in animal models as well as humans, does not negatively impact the immune system in in vivo studies, scientists at Utah State University report. The researchers, led by R.A. Burger,

Publication: Immunotherapy Weekly

Assay to detect H5N1 oseltamivir resistance.(Drug overview)
To the Editor: Oseltamivir is a neuraminidase inhibitor approved for treatment and prevention of influenza virus infection. Oseltamivir resistance caused by a single amino acid substitution from histidine (H) to tyrosine (Y) at position 274 of the neuraminidase active site has been reported in

Publication: Emerging Infectious Diseases

Oseltamivir prescribing in pharmacy-benefits database, United States, 2004-20...
We reviewed information from a US pharmacy benefits manager database from 2004 through 2005 during periods with little influenza activity. We calculated rates of oseltamivir prescriptions to enrollees. Prescription rates increased significantly from 27.3/100,000 in 2004 to 134/100,000 in 2005

Publication: Emerging Infectious Diseases